At the news
? NEUTRALIMPACT 2/10 144 filed Nov 9, 2026 at 17:32 ET
Director James R. Tobin filed a Form 144 notice of intent to sell 4,059 shares of TransMedics Group, Inc. common stock, with an estimated aggregate market value of approximately $385,468 based on the filing date. The shares were acquired through restricted stock grants in 2024, 2025, and 2026, and the sale is planned for or around November 9, 2026.
- James R. Tobin, a director of TransMedics Group, Inc., filed a Form 144 on November 9, 2026.
- The proposed sale involves 4,059 shares of common stock.
- Estimated aggregate market value of the proposed sale is approximately $385,468.
- Shares were acquired via restricted stock grants on May 23, 2024 (1,193 shares), May 22, 2025 (732 shares), and May 20, 2026 (2,134 shares).
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access